USP44 and central nervous system cancer: USP44 expression level is significantly upregulated in glioma and gastric cancer (Nishimura et al., 2017; Zou et al., 2017), whereas it's downregulated in lung cancer and colorectal adenomas (Sloane et al., 2014; Zhang et al., 2012).